GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » Debt-to-EBITDA
中文

Nutex Health (Nutex Health) Debt-to-EBITDA : -3.16 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Nutex Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nutex Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $20.1 Mil. Nutex Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $255.7 Mil. Nutex Health's annualized EBITDA for the quarter that ended in Dec. 2023 was $-87.2 Mil. Nutex Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -3.16.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Nutex Health's Debt-to-EBITDA or its related term are showing as below:

NUTX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -18.91   Med: 0.95   Max: 3.15
Current: -18.91

During the past 5 years, the highest Debt-to-EBITDA Ratio of Nutex Health was 3.15. The lowest was -18.91. And the median was 0.95.

NUTX's Debt-to-EBITDA is ranked worse than
100% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs NUTX: -18.91

Nutex Health Debt-to-EBITDA Historical Data

The historical data trend for Nutex Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutex Health Debt-to-EBITDA Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
3.15 0.95 0.97 -0.68 -18.91

Nutex Health Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.57 -100.82 18.25 20.60 -3.16

Competitive Comparison of Nutex Health's Debt-to-EBITDA

For the Health Information Services subindustry, Nutex Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nutex Health's Debt-to-EBITDA falls into.



Nutex Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nutex Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(20.076 + 255.681) / -14.581
=-18.91

Nutex Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(20.076 + 255.681) / -87.164
=-3.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Nutex Health  (NAS:NUTX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Nutex Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nutex Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutex Health (Nutex Health) Business Description

Traded in Other Exchanges
N/A
Address
6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081
Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Executives
Thomas T. Vo director, officer: Chairman, CEO 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio officer: Chief Operating Officer 6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates officer: Chief Financial Officer 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem director 700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery officer: Chief Legal Off. & Secretary 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters director 2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites director 3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc 10 percent owner 2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen officer: Chief Financial Officer 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion director C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel officer: Chief Medical Information Off 5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg officer: President of subsidiary 10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc 10 percent owner 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081